{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:50:23Z","timestamp":1793875823456,"version":"4.7.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T00:00:00Z","timestamp":1340668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1245\/s10434-012-2452-x","type":"journal-article","created":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T02:04:58Z","timestamp":1340676298000},"page":"4085-4093","source":"Crossref","is-referenced-by-count":5,"title":["Race and the Molecular Origins of Breast Cancer in Chinese Women"],"prefix":"10.1245","volume":"19","author":[{"given":"Margaret","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Warhol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis","family":"August","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,26]]},"reference":[{"key":"2452_CR1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng.318","volume":"41","author":"W Zheng","year":"2009","unstructured":"Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41:324\u20138.","journal-title":"Nat Genet."},{"key":"2452_CR2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","volume":"61","author":"R Siegel","year":"2011","unstructured":"Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212\u201336.","journal-title":"CA Cancer J Clin."},{"key":"2452_CR3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.20134","volume":"61","author":"C DeSantis","year":"2011","unstructured":"DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409\u201318.","journal-title":"CA Cancer J Clin."},{"key":"2452_CR4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ijc.10415","volume":"99","author":"D Deapen","year":"2002","unstructured":"Deapen D, Liu L, Perkins C, Bernstein L, Ross RK. Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer. 2002;99:747\u201350.","journal-title":"Int J Cancer."},{"key":"2452_CR5","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/jnci\/85.22.1819","volume":"85","author":"RG Ziegler","year":"1993","unstructured":"Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993;85:1819\u201327.","journal-title":"J Natl Cancer Inst."},{"key":"2452_CR6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10549-009-0385-2","volume":"117","author":"A Kwong","year":"2009","unstructured":"Kwong A, Wong LP, Wong HN, Law FB, Ng EK, Tang YH, et al. A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat. 2009;117:683\u20136.","journal-title":"Breast Cancer Res Treat."},{"key":"2452_CR7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/humu.9083","volume":"20","author":"X Zhi","year":"2002","unstructured":"Zhi X, Szabo C, Chopin S, Suter N, Wang QS, Ostrander EA, et al. BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. Hum Mutat. 2002;20:474.","journal-title":"Hum Mutat."},{"key":"2452_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2407-4-82","volume":"4","author":"W Han","year":"2004","unstructured":"Han W, Kim SW, Park IA, Kang D, Kim SW, Youn YK, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer. 2004;4: 82.","journal-title":"BMC Cancer."},{"key":"2452_CR9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.10154","volume":"20","author":"A Liede","year":"2002","unstructured":"Liede A, Narod SA. Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat. 2002;20:413\u201324.","journal-title":"Hum Mutat."},{"key":"2452_CR10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1054\/bjoc.1999.0960","volume":"82","author":"JH Sng","year":"2000","unstructured":"Sng JH, Chang J, Feroze F, Rahman N, Tan W, Lim S, et al. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer. 2000;82:538\u201342.","journal-title":"Br J Cancer."},{"key":"2452_CR11","doi-asserted-by":"crossref","first-page":"e2024","DOI":"10.1371\/journal.pone.0002024","volume":"3","author":"GT Toh","year":"2008","unstructured":"Toh GT, Kang P, Lee SS, Lee DS, Lee SY, Selamat S, et al. BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history. PLoS One. 2008;3:e2024.","journal-title":"PLoS One."},{"key":"2452_CR12","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","volume":"25","author":"L Harris","year":"2007","unstructured":"Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287\u2013312.","journal-title":"J Clin Oncol."},{"key":"2452_CR13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMra0801289","volume":"360","author":"C Sotiriou","year":"2009","unstructured":"Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med. 2009;360:790\u2013800.","journal-title":"N Engl J Med."},{"key":"2452_CR14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00432-006-0105-9","volume":"132","author":"CG Song","year":"2006","unstructured":"Song CG, Hu Z, Wu J, Luo JM, Shen ZZ, Huang W, et al. The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol. 2006;132:617\u201326.","journal-title":"J Cancer Res Clin Oncol."},{"key":"2452_CR15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJMra072367","volume":"358","author":"CM Croce","year":"2008","unstructured":"Croce CM, Oncogenes and cancer. N Engl J Med. 2008;358:502\u201311.","journal-title":"N Engl J Med."},{"key":"2452_CR16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/ijc.22432","volume":"120","author":"TH Keegan","year":"2007","unstructured":"Keegan TH, Gomez SL, Clarke CA, Chan JK, Glaser SL. Recent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California. Int J Cancer. 2007;120:1324\u20139.","journal-title":"Int J Cancer."},{"key":"2452_CR17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1006468514396","volume":"63","author":"SH Cheng","year":"2000","unstructured":"Cheng SH, Tsou MH, Liu MC, Jian JJ, Cheng JC, Leu SY, et al. Unique features of breast cancer in Taiwan. Breast Cancer Res Treat. 2000;63:213\u201323.","journal-title":"Breast Cancer Res Treat."},{"key":"2452_CR18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/carcin\/bgn024","volume":"29","author":"SS Lum","year":"2008","unstructured":"Lum SS, Chua HW, Li H, Li WF, Rao N, Wei J, et al. MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population. Carcinogenesis. 2008;29:754\u201361.","journal-title":"Carcinogenesis."},{"key":"2452_CR19","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1158\/1078-0432.CCR-04-0085","volume":"10","author":"K Yu","year":"2004","unstructured":"Yu K, Lee CH, Tan PH, Tan P. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res. 2004;10:5508\u201317.","journal-title":"Clin Cancer Res."},{"key":"2452_CR20","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2004.04.179","volume":"22","author":"DH Choi","year":"2004","unstructured":"Choi DH, Lee MH, Bale AE, Carter D, Haffty BG. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol. 2004;22:1638\u201345.","journal-title":"J Clin Oncol."},{"key":"2452_CR21","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/ijc.22269","volume":"119","author":"MU Rashid","year":"2006","unstructured":"Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, et al. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer. 2006;119:2832\u20139.","journal-title":"Int J Cancer."},{"key":"2452_CR22","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1158\/1055-9965.EPI-04-0932","volume":"14","author":"YC Shen","year":"2005","unstructured":"Shen YC, Chang CJ, Hsu C, Cheng CC, Chiu CF, Cheng AL. Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiol Biomark Prev. 2005;14:1986\u201390.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"2452_CR23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12325-008-0057-3","volume":"25","author":"W Chen","year":"2008","unstructured":"Chen W, Yurong S, Liansheng N. Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: not present in the Chinese familial breast cancer population. Adv Ther. 2008;25:496\u2013501.","journal-title":"Adv Ther."},{"key":"2452_CR24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.2007.15.1068","volume":"26","author":"JA Sparano","year":"2008","unstructured":"Sparano JA, Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol. 2008;26:721\u20138.","journal-title":"J Clin Oncol."},{"key":"2452_CR25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00439-009-0626-9","volume":"125","author":"Y Bosse","year":"2009","unstructured":"Bosse Y, Bacot F, Montpetit A, Rung J, Qu HQ, Engert JC, et al. Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans. Hum Genet. 2009;125:305\u201318.","journal-title":"Hum Genet."},{"key":"2452_CR26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra0905980","volume":"363","author":"TA Manolio","year":"2010","unstructured":"Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166\u201376.","journal-title":"N Engl J Med."},{"key":"2452_CR27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/BD-2004-19102","volume":"19","author":"JP Struewing","year":"2004","unstructured":"Struewing JP. Genomic approaches to identifying breast cancer susceptibility factors. Breast Dis. 2004;19:3\u20139.","journal-title":"Breast Dis."},{"key":"2452_CR28","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/cncr.22634","volume":"109","author":"DA Ralph","year":"2007","unstructured":"Ralph DA, Zhao LP, Aston CE, Manjeshwar S, Pugh TW, DeFreese DC, et al. Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk. Cancer. 2007;109:1940\u20138.","journal-title":"Cancer."},{"key":"2452_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/BD-2006-23104","volume":"23","author":"JP Evans","year":"2005","unstructured":"Evans JP, Skrzynia C, Susswein L, Harlan M. Genetics and the young woman with breast cancer. Breast Dis. 2005;23:17\u201329.","journal-title":"Breast Dis."},{"key":"2452_CR30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/BD-2006-23105","volume":"23","author":"JC Samuel","year":"2005","unstructured":"Samuel JC, Ollila DW. Prophylaxis and screening options: recommendations for young women with BRCA mutations. Breast Dis. 2005;23:31\u20135.","journal-title":"Breast Dis."},{"key":"2452_CR31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-1-59745-416-2_25","volume":"471","author":"MS Simon","year":"2009","unstructured":"Simon MS, Petrucelli N. Hereditary breast and ovarian cancer syndrome: the impact of race on uptake of genetic counseling and testing. Methods Mol Biol. 2009;471:487\u2013500.","journal-title":"Methods Mol Biol."},{"key":"2452_CR32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/00981380802173509","volume":"47","author":"A Werner-Lin","year":"2008","unstructured":"Werner-Lin A. Beating the biological clock: the compressed family life cycle of young women with BRCA gene alterations. Soc Work Health Care. 2008;47:416\u201337.","journal-title":"Soc Work Health Care."},{"key":"2452_CR33","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","volume":"298","author":"EM John","year":"2007","unstructured":"John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial\/ethnic groups. JAMA. 2007;298:2869\u201376.","journal-title":"JAMA."},{"key":"2452_CR34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1399-0004.2007.00773.x","volume":"71","author":"YK Lim","year":"2007","unstructured":"Lim YK, Lau PT, Ali AB, Lee SC, Wong JE, Putti TC, et al. Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer. Clin Genet. 2007;71:331\u201342.","journal-title":"Clin Genet."},{"key":"2452_CR35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jmg.2007.057174","volume":"46","author":"KY Chan","year":"2009","unstructured":"Chan KY, Liu W, Long JR, Yip SP, Chan SY, Shu XO, et al. Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women. J Med Genet. 2009;46:32\u20139.","journal-title":"J Med Genet."},{"key":"2452_CR36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10689-007-9155-7","volume":"7","author":"A Kwong","year":"2008","unstructured":"Kwong A, Wong LP, Chan KY, Ma ES, Khoo US, Ford JM. Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family. Fam Cancer. 2008;7:125\u201333.","journal-title":"Fam Cancer."},{"key":"2452_CR37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1158\/1055-9965.EPI-04-0414","volume":"14","author":"J Shen","year":"2005","unstructured":"Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, et al. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomark Prev. 2005;14:336\u201342.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"2452_CR38","first-page":"217","volume":"10","author":"EJ Duell","year":"2001","unstructured":"Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CK, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomark Prev. 2001;10:217\u201322.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"2452_CR39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00008571-200206000-00010","volume":"12","author":"SU Kim","year":"2002","unstructured":"Kim SU, Park SK, Yoo KY, Yoon KS, Choi JY, Seo JS, et al. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics. 2002;12:335\u20138.","journal-title":"Pharmacogenetics."},{"key":"2452_CR40","first-page":"370","volume":"35","author":"MJ Jin","year":"2006","unstructured":"Jin MJ, Chen K, Zhang SS, Zhang YJ, Ren YJ, Xu H, et al. [Association of single nucleotide polymorphisms and haplotypes in DNA repair gene XRCC1 with susceptibility of breast cancer]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006;35:370\u20136.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban."},{"key":"2452_CR41","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1158\/0008-5472.CAN-07-0467","volume":"67","author":"BL Yaspan","year":"2007","unstructured":"Yaspan BL, Breyer JP, Cai Q, Dai Q, Elmore JB, Amundson I, et al. Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk. Cancer Res. 2007;67:5673\u201382.","journal-title":"Cancer Res."},{"key":"2452_CR42","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1158\/1055-9965.EPI-07-2680","volume":"17","author":"LC Sakoda","year":"2008","unstructured":"Sakoda LC, Blackston C, Doherty JA, Ray RM, Lin MG, Stalsberg H, et al. Polymorphisms in steroid hormone biosynthesis genes and risk of breast cancer and fibrocystic breast conditions in Chinese women. Cancer Epidemiol Biomark Prev. 2008;17:1066\u201373.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"2452_CR43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1158\/1055-9965.709.13.5","volume":"13","author":"W Zheng","year":"2004","unstructured":"Zheng W, Gao YT, Shu XO, Wen W, Cai Q, Dai Q, et al. Population-based case\u2013control study of CYP11A gene polymorphism and breast cancer risk. Cancer Epidemiol Biomark Prev. 2004;13:709\u201314.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"2452_CR44","first-page":"5979","volume":"61","author":"S Gruvberger","year":"2001","unstructured":"Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001;61:5979\u201384.","journal-title":"Cancer Res."},{"key":"2452_CR45","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/jjco\/hyn097","volume":"38","author":"M Hamaguchi","year":"2008","unstructured":"Hamaguchi M, Nishio M, Toyama T, Sugiura H, Kondo N, Fujii Y, et al. Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers. Jpn J Clin Oncol. 2008;38:734\u201342.","journal-title":"Jpn J Clin Oncol."},{"key":"2452_CR46","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1158\/0008-5472.CAN-10-2733","volume":"71","author":"Q Cai","year":"2011","unstructured":"Cai Q, Wen W, Qu S, Li G, Egan KM, Chen K, et al. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of Chinese, Japanese, and European ancestry. Cancer Res. 2011;71:1344\u201355.","journal-title":"Cancer Res."},{"key":"2452_CR47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ng2030","volume":"39","author":"T Sun","year":"2007","unstructured":"Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet. 2007;39:605\u201313.","journal-title":"Nat Genet."},{"key":"2452_CR48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711\u201323.","journal-title":"N Engl J Med."},{"key":"2452_CR49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2407-7-173","volume":"7","author":"L Wang","year":"2007","unstructured":"Wang L, Li D, Fu Z, Li H, Jiang W, Li D. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer. 2007;7:173.","journal-title":"BMC Cancer."},{"key":"2452_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:BREA.0000032918.89120.8e","volume":"86","author":"A Ghaderi","year":"2004","unstructured":"Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat. 2004;86:1\u20137.","journal-title":"Breast Cancer Res Treat."},{"key":"2452_CR51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cancergencyto.2005.07.020","volume":"165","author":"N Erfani","year":"2006","unstructured":"Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, et al. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet. 2006;165:114\u201320.","journal-title":"Cancer Genet Cytogenet."},{"key":"2452_CR52","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15287390701289966","volume":"70","author":"J Gao","year":"2007","unstructured":"Gao J, Ke Q, Ma HX, Wang Y, Zhou Y, Hu ZB, et al. Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population. J Toxicol Environ Health A. 2007;70:908\u201315.","journal-title":"J Toxicol Environ Health A."},{"key":"2452_CR53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","volume":"26","author":"M Weischer","year":"2008","unstructured":"Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol. 2008;26:542\u20138.","journal-title":"J Clin Oncol."},{"key":"2452_CR54","doi-asserted-by":"crossref","unstructured":"CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet. 2004;74:1175\u201382.","DOI":"10.1086\/421251"},{"key":"2452_CR55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ijc.11414","volume":"108","author":"A Osorio","year":"2004","unstructured":"Osorio A, Rodriguez-Lopez R, Diez O, de la Hoya M, Ignacio Martinez J, Vega A, et al. The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer. 2004;108:54\u20136.","journal-title":"Int J Cancer."},{"key":"2452_CR56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10549-007-9878-z","volume":"112","author":"DH Choi","year":"2008","unstructured":"Choi DH, Cho DY, Lee MH, Park HS, Ahn SH, Son BH, et al. The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation. Breast Cancer Res Treat. 2008;112:569\u201373.","journal-title":"Breast Cancer Res Treat."},{"key":"2452_CR57","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/hmg\/ddp078","volume":"18","author":"MS Udler","year":"2009","unstructured":"Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet. 2009;18:1692\u2013703.","journal-title":"Hum Mol Genet."},{"key":"2452_CR58","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1055-9965.EPI-08-0018","volume":"17","author":"L Raskin","year":"2008","unstructured":"Raskin L, Pinchev M, Arad C, Lejbkowicz F, Tamir A, Rennert HS, et al. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations. Cancer Epidemiol Biomark Prev. 2008;17:1060\u20135.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"2452_CR59","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/ejhg.2008.12","volume":"16","author":"KC Seng","year":"2008","unstructured":"Seng KC, Seng CK. The success of the genome-wide association approach: a brief story of a long struggle. Eur J Hum Genet. 2008;16:554\u201364.","journal-title":"Eur J Hum Genet."},{"key":"2452_CR60","doi-asserted-by":"crossref","first-page":"e1000054","DOI":"10.1371\/journal.pgen.1000054","volume":"4","author":"M Garcia-Closas","year":"2008","unstructured":"Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet. 2008;4:e1000054.","journal-title":"PLoS Genet."},{"key":"2452_CR61","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ng2075","volume":"39","author":"DJ Hunter","year":"2007","unstructured":"Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007;39:870\u20134.","journal-title":"Nat Genet."},{"key":"2452_CR62","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","volume":"447","author":"DF Easton","year":"2007","unstructured":"Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447:1087\u201393.","journal-title":"Nature."},{"key":"2452_CR63","first-page":"1","volume":"2","author":"EM Goldblatt","year":"2010","unstructured":"Goldblatt EM, Lee WH. From bench to bedside: the growing use of translational research in cancer medicine. Am J Transl Res. 2010;2:1\u201318.","journal-title":"Am J Transl Res."},{"key":"2452_CR64","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"353","author":"EH Romond","year":"2005","unstructured":"Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005;353:1673\u201384.","journal-title":"N Engl J Med."},{"key":"2452_CR65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jncimonographs\/lgr033","volume":"2011","author":"MG Daidone","year":"2011","unstructured":"Daidone MG, Zaffaroni N, Cappelletti V. Strategies to translate preclinical information to breast cancer patient benefit. J Natl Cancer Inst Monogr. 2011;2011:55\u20139.","journal-title":"J Natl Cancer Inst Monogr."},{"key":"2452_CR66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMra043186","volume":"357","author":"CA Hudis","year":"2007","unstructured":"Hudis CA. Trastuzumab-mechanism of action and use in clinical practice. N Engl J Med. 2007;357:39\u201351.","journal-title":"N Engl J Med."},{"key":"2452_CR67","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2407-11-292","volume":"11","author":"Y Su","year":"2011","unstructured":"Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, et al. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. BMC Cancer. 2011;11:292.","journal-title":"BMC Cancer."},{"key":"2452_CR68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jso.21307","volume":"100","author":"J Zhao","year":"2009","unstructured":"Zhao J, Liu H, Wang M, Gu L, Guo X, Gu F, et al. Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol. 2009;100:89\u201394.","journal-title":"J Surg Oncol."},{"key":"2452_CR69","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10549-010-1173-8","volume":"127","author":"ML Telli","year":"2011","unstructured":"Telli ML, Chang ET, Kurian AW, Keegan TH, McClure LA, Lichtensztajn D, et al. Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat. 2011;127:471\u20138.","journal-title":"Breast Cancer Res Treat."},{"key":"2452_CR70","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12032-009-9308-7","volume":"27","author":"P Xing","year":"2010","unstructured":"Xing P. Li J, Jin F. A case\u2013control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol. 2010;27:926\u201331.","journal-title":"Med Oncol."},{"key":"2452_CR71","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/ng1435","volume":"36","author":"LB Jorde","year":"2004","unstructured":"Jorde LB, Wooding SP. Genetic variation, classification and \u201crace\u201d. Nat Genet. 2004;36:S28\u201333.","journal-title":"Nat Genet."},{"key":"2452_CR72","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1038\/ng1455","volume":"36","author":"SO Keita","year":"2004","unstructured":"Keita SO, Kittles RA, Royal CD, Bonney GE, Furbert-Harris P, Dunston GM, et al. Conceptualizing human variation. Nat Genet. 2004;36:S17\u201320.","journal-title":"Nat Genet."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2452-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2452-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2452-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T22:13:26Z","timestamp":1687558406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2452-x"}},"subtitle":["Breast Cancer in Chinese Women"],"short-title":[],"issued":{"date-parts":[[2012,6,26]]},"references-count":72,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2452"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2452-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,26]]}}}